Botulinum Toxins & Dermal Fillers & Frontline TMJ & Orofacial Pain is organized by American Academy of Facial Esthetics (AAFE) and will be held from Mar 19 - 20, 2021 at Omaha, Nebraska, United States of America. Description: Botulinum Toxins & Dermal Fillers Level 1 Course: Botulinum Toxin and Dermal Fillers Live Patient Training Courses for Dental and Medical Professionals, Presented by The American Academy of Facial Esthetics (AAFE). Upon completing registration for this course you will receive email confirmation that will give you access to the Prepare On-Demand Module which includes the lecture, video and didactic portions of this course using the AAFE state of the art online education portal.  The Prepare On-Demand Module must be completed as a prerequisite to taking the Practice Live Patient Module of this training course. The Botulinum Toxin Live Patient training will take place in the morning. The Dermal Filler live patient training will be in the afternoon. Objectives: Botulinum Toxins & Dermal Fillers Level 1 Course Objectives • Patient assessment and consultation for botulinum toxins and dermal fillers • Indications and contraindications for these pharmaceutical agents • In depth instruction in the anatomy, neurophysiology, musculature and circulatory system of the oral and maxillofacial areas • Patient evaluation for the best dental and facial esthetic and therapeutic outcomes • Review of sterile technique as it relates to the use of injectable pharmacologic agents • Safety and risk issues for botulinum toxin and dermal fillers injectable therapy • Learn the physiology and pharmacology of oral and maxillo-facial injectable treatment • Integrating botulinum neurotoxin and dermal filler therapy into therapeutic and esthetic treatment plans • Volumizing nasolabial folds, marionette lines, and lifting up the corners of the mouth using anatomical landmarks • Beautiful and subtle lip enhancements by adding volume to establish proper lip and smile lines • Smoothing lip lines and eliminating vertical “smokers” lines • Learn the best treatment techniques including anatomical muscle sites, muscle depths, proper preparation and dilution for the best oral and maxillofacial therapeutic and esthetic outcomes • Botulinium toxin therapeutic treatment for bruxism to relieve TMJ syndrome • How to avoid, manage, and treat possible adverse reactions and complications • Live patient training including comprehensive diagnosis, treatment planning, proper dosing and delivery of botulinum neurotoxin and dermal fillers • Proper fee structures for oral and maxillofacial injectable treatment • All necessary office forms and informed consents needed to begin treating patients immediately • This course is recognized by and will help in securing liability insurance • Observe many model patients during the day • One on one comprehensive mentored instruction as you work hands-on your model patient

2021 Omaha Regional Hospice & Palliative Symposium: Growing Palliative Care is organized by UNMC Center for Continuing Education (CCE) and will be held on Apr 06, 2021 at Scott Conference Center, Omaha, Nebraska, United States Of America. Target Audience: This symposium is intended for physicians, nurse practitioners, physician assistants, nurses, social workers, pharmacists, chaplains, and students. Accreditation: Physicians The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses This activity is provided for 5.25 contact hours under ANCC criteria.  Overview: This one-day symposium will provide interdisciplinary dialogue on the current and future work of palliative care and hospice in the Omaha metro area and surrounding region. Topics will include updates on local clinical, advocacy, research, and educational endeavors, as well as expert speakers from neighboring regions. This symposium is designed to provide both novice and expert level content. Symposium Objectives: At the conclusion of this symposium, the participant should be better able to: • Identify current work to develop regional excellence in palliative care • Describe career opportunities for building or integrating palliative expertise into one’s individual current practice • Discuss the impact of social, emotional, and spiritual suffering on patient care • Develop strategies for effectively managing patient suffering Additional details will be posted as soon as information is available.

Updates in Rheumatology: Focus on Rheumatoid Arthritis is organized by UNMC Center for Continuing Education (CCE) and will be held on Apr 23, 2021 at Michael F Sorrell Center For Health Science Education, Omaha, Nebraska, United States of America. Target Audience: This symposium is intended for physicians, physician assistants, nurse practitioners, nurses, residents, and fellows who care for patients with rheumatologic diseases, particularly rheumatoid arthritis. Accreditation: Physicians The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses 5.25 Contact Hours Awarded Overview: This symposium will focus on the diagnosis and management of rheumatic conditions that are characterized by Rheumatoid Arthritis (RA). This will include presentations focused on Interstitial Lung Disease (ILD), preclinical RA including immune checkpoint inhibitors and lessons learned in RA, prevention and treatment of infections in immunosuppressed patients, and other rheumatic disorders. The symposium will use traditional didactic lectures from well-recognized national experts, as well as topical case presentations and open discussions. Symposium Objectives: At the conclusion of this symposium, the participant should be better able to: • Identify key contributors to the pathogenesis of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) • Characterize RA-ILD clinical manifestations, detection, diagnosis, and natural history • Discuss the potential role of available and emerging pharmaceutical modalities in the management of RA-ILD • Summarize what is known regarding the epidemiology and outcomes of serious infections in RA patients and their relationship with disease-modifying treatments • Describe approaches to predict and prevent serious infections occurring in the context of disease-modifying treatment • Describe progress that has been made in the development of predictive markers for preclinical RA and insights provided from these advancements for future identification and early intervention for the disease • Describe progress in the use of autoantibodies as biomarkers in patients with seronegative RA • Describe recent advancements in immune checkpoint inhibitors both in application to RA and the ways in which they may exacerbate the disease process

Extraordinary Innovations and Emerging Trends in Transplantation and Oncology Co-provided conference with Nebraska Medicine is organized by OptumHealth Education (OHE) and will be held from Jul 13 - 14, 2021 at Omaha, Nebraska, United States of America. Additional details will be posted as soon as information is available.

47th Annual National Society for Histotechnology (NSH) Symposium/Convention is organized by National Society for Histotechnology (NSH) and will be held from Sep 16 - 23, 2021 at Omaha, Nebraska, United States of America. Additional details will be posted as soon as they are available.